Thomas Stinchcombe, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Takeda, Gilead Sciences, Coherus Biosciences Boehringer Ingelheim, Pfizer Abbvie, Janssen Oncology
    Topic:
    Lung cancer
    Date added:
    07/06/2025
    Date updated:
    07/06/2025
    Relationship end date:
    07/06/2025
  • Attribution:
    Other
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Seagen, Mirati Therapeutics, Nuvalent, Inc. Boehringer Ingelheim
    Topic:
    Institution (clinical trials)
    Date added:
    07/06/2025
    Date updated:
    07/06/2025
    Relationship end date:
    07/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GSK, Genentech, Merck, Seagen
    Topic:
    DMSB
    Date added:
    07/06/2025
    Date updated:
    07/06/2025
    Relationship end date:
    07/06/2025
Return to Best of ASCO 2025, Omaha